Insider sales disclosed at CAMT (NASDAQ: CAMT) include three transactions totaling ~$816K

Rhea-AI Filing Summary

CAMT submission of Form 144 reporting proposed or past resale activity in ordinary shares by a holder. The filing lists two groups of Restricted Stock Units granted on 01/16/2023 (3,049 units) and 01/24/2022 (4,516 units) and discloses three reported sales during the past three months: $197,085.00 on 11/26/2025 (1,877 shares), $250,768.00 on 12/02/2025 (2,239 shares), and $368,760.90 on 02/24/2026 (2,271 shares).

Insights

Securities Compliance Counsel

Form 144 documents recent insider resale activity and RSU grant history.

The filing lists RSU grants dated 01/24/2022 and 01/16/2023 of 4,516 and 3,049 units respectively, and reports three sales with explicit share counts and dollar amounts.

These entries are routine Rule 144 disclosures that track proposed or completed resale transactions; timing and any broker or distribution method are not stated in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	805	131842.90	45449306	02/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/16/2023	Restricted Stock Units	Issuer			3049	01/16/2023	N/A
Ordinary	01/24/2022	Restricted Stock Units	Issuer			4516	01/24/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Orit Geva-Dvash INDUSTRIAL ZONE PO BOX 544 MIGDAL HAEMEK L3 2310501	Ordinary	11/26/2025	1877	197085.00
Orit Geva-Dvash INDUSTRIAL ZONE PO BOX 544 MIGDAL HAEMEK L3 2310501	Ordinary	12/02/2025	2239	250768.00
Orit Geva-Dvash INDUSTRIAL ZONE PO BOX 544 MIGDAL HAEMEK L3 2310501	Ordinary	02/24/2026	2271	368760.90

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CAMT's Form 144 disclose about recent insider sales?

It discloses three sales with share counts and dollar amounts: 1,877 shares for $197,085.00, 2,239 shares for $250,768.00, and 2,271 shares for $368,760.90, dated between 11/26/2025 and 02/24/2026.

Does the filing state who sold the CAMT shares?

Yes; the name shown is Orit Geva-Dvash with the listed address. The filing ties the three reported sales to that individual in the provided excerpt.

Are any proceeds or uses of proceeds disclosed in the CAMT Form 144?

The excerpt reports the dollar amounts of the reported sales but does not state who received proceeds or describe any use of proceeds in the provided content.

Does the Form 144 register shares from equity awards for CAMT?

The filing lists two Restricted Stock Unit grants—3,049 RSUs dated 01/16/2023 and 4,516 RSUs dated 01/24/2022—as part of the securities information in the excerpt.

Do the sales in the filing indicate planned future sales under Rule 144?

The form reports past sales within the past three months and provides RSU grant details; it does not specify future planned sales or an aggregate offering amount in the provided excerpt.